AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 268: E336-E342, 1995;
0193-1849/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boschero, A. C.
Right arrow Articles by Atwater, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boschero, A. C.
Right arrow Articles by Atwater, I.

AJP - Endocrinology and Metabolism, Vol 268, Issue 2 E336-E342, Copyright © 1995 by American Physiological Society


ARTICLES

Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors

A. C. Boschero, M. Szpak-Glasman, E. M. Carneiro, S. Bordin, I. Paul, E. Rojas and I. Atwater
Laboratory of Cell Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

cDNAs encoding for M1 and M3 muscarinic acetylcholine (ACh) receptors were detected in rat pancreatic islet cells by polymerase chain reaction (PCR) amplification techniques. A new cholinergic agonist, oxotremorine-m (oxo-m), in the presence of glucose (5.6 mM), produced a dose-dependent potentiation of insulin secretion saturating at approximately 5 microM. This effect was suppressed by the L-type Ca2+ channel blocker nifedipine. Higher doses of oxo-m (50 microM) induced a biphasic insulin response both at low (5.6 mM) or high (16.7 mM) glucose concentrations. In a Ca(2+)-deficient medium containing glucose (5.6 mM), oxo-m evoked only a reduced first phase of insulin secretion. The potentiating effects of oxo-m were inhibited by the muscarinic receptor antagonists 4-diphenylacetoxy-N-methylpiperidine methiodide (M3), hexahydro-sila-difenidol hydrochloride, p-fluoro analogue (M3 > M1 > M2), and pirenzepine (M1) in a dose-dependent manner; half-maximal inhibitory concentration values were approximately 5, 20, and 340 nM, respectively. The PCR results demonstrate the presence of M1 and M3 muscarinic ACh receptors in the islet tissue, and the secretion data strongly suggest that the potentiation of glucose-induced insulin release evoked by oxo-m depends on the activation of a muscarinic M3-subtype receptor present in the beta-cell membrane.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Mitrani, M. Srinivasan, C. Dodds, and M. S. Patel
Role of the autonomic nervous system in the development of hyperinsulinemia by high-carbohydrate formula feeding to neonatal rats
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1069 - E1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. Cunha, E. M. Carneiro, M. d. C. Alves, A. G. Jorge, S. M. de Sousa, A. C. Boschero, M. J. A. Saad, L. A. Velloso, and E. M. Rocha
Insulin secretion by rat lachrymal glands: effects of systemic and local variables
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E768 - E775.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Wettschureck and S. Offermanns
Mammalian G Proteins and Their Cell Type Specific Functions
Physiol Rev, October 1, 2005; 85(4): 1159 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Ferreira, E. Filiputti, V. C. Arantes, L. F. Stoppiglia, E. P. Araujo, V. Delghingaro-Augusto, M. Q. Latorraca, M. H. Toyama, A. C. Boschero, and E. M. Carneiro
Decreased Cholinergic Stimulation of Insulin Secretion by Islets from Rats Fed a Low Protein Diet Is Associated with Reduced Protein Kinase C{alpha} Expression
J. Nutr., March 1, 2003; 133(3): 695 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Q. Latorraca, M. A. B. Reis, E. M. Carneiro, M. A. R. Mello, L. A. Velloso, M. J. A. Saad, and A. C. Boschero
Protein Deficiency and Nutritional Recovery Modulate Insulin Secretion and the Early Steps of Insulin Action in Rats
J. Nutr., October 1, 1998; 128(10): 1643 - 1649.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. A. Love, N. W. Richards, C. Owyang, and D. C. Dawson
Muscarinic modulation of voltage-dependent Ca2+ channels in insulin-secreting HIT-T15 cells
Am J Physiol Gastrointest Liver Physiol, February 1, 1998; 274(2): G397 - G405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Karlsson, F. Sundler, and B. Ahren
Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect
Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E124 - E129.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online